# FDA 483 - Palisades Compounding Pharmacy - March 15, 2023

Source: https://www.keypedia.com/records/483/palisades-compounding-pharmacy/59444b9e-4f96-4139-b08e-3de81dbf6936

> FDA 483 for Palisades Compounding Pharmacy on March 15, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Palisades Compounding Pharmacy
- Inspection Date: 2023-03-15
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Palisades Compounding Pharmacy in Pacific Palisades, CA, a producer of non-sterile drugs, was cited for significant deficiencies during an FDA inspection. Observations included inadequate segregation and cleaning practices for hazardous drug production, leading to potential cross-contamination. Additionally, the firm was found to have used expired excipients in the production of finished drug products, compromising their quality.

## Related Documents

- [483 - 2023-03-15](https://www.keypedia.com/records/483/palisades-compounding-pharmacy/6b6843a2-7e35-4473-b9a8-12cef85c7019)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/darren-s-brown/389a4d1f-7f34-42cd-bdc8-5bebd41aff56)

Company: https://www.keypedia.com/companies/palisades-compounding-pharmacy/5084644c-6708-4f0b-bf9c-e30cfbcd969b

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6